Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the release of its 2025 Sustainability Impact ...

Alfonso Eduardo acquired 4,300 common shares on March 2, 2026, at around $17.90 per share, for a total transaction value of ~$77,000. Bausch + Lomb, matched his purchase with restricted stock units, ...

A new Fox Nation special goes into the harrowing case of Chris Watts' plot to murder his pregnant wife and their two young daughters. The new special will be available to watch on Fox One starting on ...

Forbes contributors publish independent expert analyses and insights. Hugh McIntyre covers music, with a focus on the global charts. Chris Stapleton is one of the most successful musicians in country ...

BHC lost $0.30 in earnings per share, compared to the Street’s expectation of a $0.42 EPS. The GAAP net loss of $112 million is down from $157 million posted last year. Chief Executive Officer Thomas ...

Ratings for Bausch & Lomb (NYSE:BLCO) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...

Bausch + Lomb set new growth targets for 2026 after solid performances in its core businesses drove fourth-quarter revenue higher. The eye-health company expects revenue for 2026 to grow to $5.38 ...

VAUGHAN, Ontario (AP) — VAUGHAN, Ontario (AP) — Bausch + Lomb Corporation (BLCO) on Wednesday reported a loss of $58 million in its fourth quarter. On a per-share basis, the Vaughan, Ontario-based ...

Experience alone used to be enough. Learn your craft. Do the work. Repeat. That world doesn’t exist anymore. Today, standing still isn’t neutral – it’s falling behind. Artificial intelligence makes ...

There's a good reason why Bausch Health shares are experiencing yet another pullback. A recent clinical trial setback points to further trouble ahead. Buying on this latest round of weakness could ...